Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Harada, T. Oga, K. Murase, Y. Toyama, K. Aihara, Y. Chihara, C. Yoshimura, T. Hitomi, T. Handa, T. Tsuboi, M. Mishima, K. Chin (Kyoto, Japan). Visceral fat in non-to-moderate and severe obstructive sleep apnoea. Eur Respir J 2012; 40: Suppl. 56, 3816

Member's Comments

No comment yet.

Related content which might interest you: Adiponectin and epicardial fat in patients with obstructive sleep apnoea Source: International Congress 2019 – Diagnostic issues in obstructive sleep apnoea Year: 2019 Leptin in obstructive sleep apnea Source: Eur Respir J 2001; 18: Suppl. 33, 333s Year: 2001 Unrecognised obstructive sleep apnoea is common in severe peripheral arterial disease Source: Eur Respir J 2013; 41: 616-620 Year: 2013 Obesity and daytime somnolence at patients with obstructive sleep apnea and sistemic hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 562s Year: 2002 Metabolic syndrome in moderate to severe obstructive sleep apnea? Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification Year: 2020 Relationship between neck fat volume and severity of obstructive sleep apnea Source: Virtual Congress 2021 – Pathophysiology and clinical consequences of obstructive sleep apnoea Year: 2021 Metabolic syndrome in obstructive sleep apnoea patients Source: Annual Congress 2007 - Sleep apnoea Year: 2007 Association between visceral fat tissue, bone densitometry and obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2007 - Systemic effects of obstructive sleep apnoea Year: 2007 Obstructive sleep apnoea and metabolic impairment in severe obesity Source: Eur Respir J 2011; 38: 1089-1097 Year: 2011 Comorbidities of obstructive sleep apnoea syndrome Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities Year: 2011 Body composition correlates with the severity of obstructive sleep apnea syndrome Source: Annual Congress 2008 - Weight control and comorbidity in obstructive sleep apnoea Year: 2008 Pulmonary hypertension and obstructive sleep apnea syndrome -Marmara Universitypediatric sleep laboratory experience Source: Virtual Congress 2020 – Respiratory physiology and sleep: what is new? Year: 2020 Severe obstructive sleep apnea in spinal muscle atrophy Source: Eur Respir J 2003; 22: Suppl. 45, 466s Year: 2003 Can leptin be used to treat obstructive sleep apnoea? Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside Year: 2019 Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010 Airway inflammation in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 274s Year: 2002 Chronic hypercapnia in morbidly obese patients with obstructive sleep apnea syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 569s Year: 2005 Awakening headaches are associated with obstructive sleep apnea Source: Eur Respir J 2002; 20: Suppl. 38, 452s Year: 2002 Vasoconstriction during the night in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 419s Year: 2006 Chronic cough in patients with obstructive sleep apnea. Source: International Congress 2018 – Obesity: comorbidities Year: 2018